Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ASND

Ascendis Pharma

$33.96

0.4 (1.19%)

04:55
11/03/17
11/03
04:55
11/03/17
04:55
Conference/Events
Ascendis Pharma management to meet with Wedbush »

Meeting with CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

  • 06

    Nov

  • 14

    Nov

ASND

Ascendis Pharma

$33.56

-0.42 (-1.24%)

04:55
11/02/17
11/02
04:55
11/02/17
04:55
Conference/Events
Ascendis Pharma management to meet with Wedbush »

Meeting with CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

  • 03

    Nov

  • 06

    Nov

ASND

Ascendis Pharma

$31.98

-0.27 (-0.84%)

10:59
10/30/17
10/30
10:59
10/30/17
10:59
Conference/Events
Ascendis Pharma management to meet with Wedbush »

Meeting with CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

  • 06

    Nov

Over a month ago
ASND

Ascendis Pharma

$37.10

0.97 (2.68%)

04:40
09/27/17
09/27
04:40
09/27/17
04:40
Syndicate
Ascendis Pharma 3.8M share Spot Secondary priced at $35.50 »

The deal priced in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

CTAS

Cintas

$136.10

-0.77 (-0.56%)

, MU

Micron

$34.18

-0.69 (-1.98%)

17:35
09/26/17
09/26
17:35
09/26/17
17:35
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Cintas…

CTAS

Cintas

$136.10

-0.77 (-0.56%)

MU

Micron

$34.18

-0.69 (-1.98%)

EDIT

Editas Medicine

$20.30

-0.83 (-3.93%)

TWTR

Twitter

$16.59

-0.39 (-2.30%)

NKE

Nike

$53.70

0.47 (0.88%)

KRNT

Kornit Digital

$17.15

-0.15 (-0.87%)

WLKP

Westlake Chemical Partners

$24.10

0.15 (0.63%)

ITCI

Intra-Cellular

$19.23

-0.57 (-2.88%)

ASND

Ascendis Pharma

$37.10

0.97 (2.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

  • 27

    Sep

  • 27

    Sep

  • 28

    Sep

ASND

Ascendis Pharma

$37.10

0.97 (2.68%)

16:40
09/26/17
09/26
16:40
09/26/17
16:40
Syndicate
Ascendis Pharma $125M Spot Secondary; price range $35.00-$36.00 »

JPMorgan, BofA/Merrill…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASND

Ascendis Pharma

$37.10

0.97 (2.68%)

16:21
09/26/17
09/26
16:21
09/26/17
16:21
Syndicate
Ascendis Pharma announces offering of $125M of ADSs »

Ascendis Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASND

Ascendis Pharma

$36.13

1.89 (5.52%)

14:48
09/26/17
09/26
14:48
09/26/17
14:48
Recommendations
Ascendis Pharma analyst commentary at BofA/Merrill »

BofA/Merrill ups Ascendis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASND

Ascendis Pharma

$36.13

1.89 (5.52%)

14:31
09/26/17
09/26
14:31
09/26/17
14:31
Recommendations
Ascendis Pharma analyst commentary at BofA/Merrill »

Ascendis Pharma price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASND

Ascendis Pharma

$36.13

1.89 (5.52%)

08:07
09/26/17
09/26
08:07
09/26/17
08:07
Hot Stocks
Ascendis Pharma announces dosing of subjects in Phase 1 trial of TransCon PTH »

Ascendis Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.